243 related articles for article (PubMed ID: 12200202)
1. Vasopressin as a target for antidepressant development: an assessment of the available evidence.
Scott LV; Dinan TG
J Affect Disord; 2002 Nov; 72(2):113-24. PubMed ID: 12200202
[TBL] [Abstract][Full Text] [Related]
2. Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression.
Scott LV; Dinan TG
Life Sci; 1998; 62(22):1985-98. PubMed ID: 9627097
[TBL] [Abstract][Full Text] [Related]
3. The role of the arginine vasopressin Avp1b receptor in the acute neuroendocrine action of antidepressants.
Stewart LQ; Roper JA; Young WS; O'Carroll AM; Lolait SJ
Psychoneuroendocrinology; 2008 May; 33(4):405-15. PubMed ID: 18243568
[TBL] [Abstract][Full Text] [Related]
4. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP.
Connan F; Lightman SL; Landau S; Wheeler M; Treasure J; Campbell IC
J Psychiatr Res; 2007; 41(1-2):131-43. PubMed ID: 16455105
[TBL] [Abstract][Full Text] [Related]
5. Hypothalamo-pituitary-adrenal cortical responses to low-dose physostigmine and arginine vasopressin administration: sex differences between major depressives and matched control subjects.
Rubin RT; O'Toole SM; Rhodes ME; Sekula LK; Czambel RK
Psychiatry Res; 1999 Dec; 89(1):1-20. PubMed ID: 10643873
[TBL] [Abstract][Full Text] [Related]
6. Reduced vasopressin receptors activation mediates the anti-depressant effects of fluoxetine and venlafaxine in bulbectomy model of depression.
Poretti MB; Sawant RS; Rask-Andersen M; de Cuneo MF; Schiöth HB; Perez MF; Carlini VP
Psychopharmacology (Berl); 2016 Mar; 233(6):1077-86. PubMed ID: 26700241
[TBL] [Abstract][Full Text] [Related]
7. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
[TBL] [Abstract][Full Text] [Related]
8. Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation.
Aguilera G; Rabadan-Diehl C
Regul Pept; 2000 Dec; 96(1-2):23-9. PubMed ID: 11102648
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of HPA axis hyperactivity and simultaneous clinical deterioration in a depressed patient treated with mirtazapine.
Schüle C; Baghai T; Zwanzger P; Rupprecht R
World J Biol Psychiatry; 2001 Apr; 2(2):103-5. PubMed ID: 12587193
[TBL] [Abstract][Full Text] [Related]
10. Stress responsive neurohormones in depression and anxiety.
Ströhle A; Holsboer F
Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
[TBL] [Abstract][Full Text] [Related]
11. Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response.
Nikisch G; Mathé AA; Czernik A; Thiele J; Bohner J; Eap CB; Agren H; Baumann P
Psychopharmacology (Berl); 2005 Oct; 181(4):751-60. PubMed ID: 15988572
[TBL] [Abstract][Full Text] [Related]
12. Effect of repeated exposure to alcohol on the response of the hypothalamic-pituitary-adrenal axis of the rat: I. Role of changes in hypothalamic neuronal activity.
Lee S; Schmidt ED; Tilders FJ; Rivier C
Alcohol Clin Exp Res; 2001 Jan; 25(1):98-105. PubMed ID: 11198721
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant-like effect of geniposide on chronic unpredictable mild stress-induced depressive rats by regulating the hypothalamus-pituitary-adrenal axis.
Cai L; Li R; Tang WJ; Meng G; Hu XY; Wu TN
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1332-41. PubMed ID: 25914157
[TBL] [Abstract][Full Text] [Related]
14. Desmopressin augments pituitary-adrenal responsivity to corticotropin-releasing hormone in subjects with chronic fatigue syndrome and in healthy volunteers.
Scott LV; Medbak S; Dinan TG
Biol Psychiatry; 1999 Jun; 45(11):1447-54. PubMed ID: 10356627
[TBL] [Abstract][Full Text] [Related]
15. Association analysis for corticotropin releasing hormone polymorphisms with the risk of major depressive disorder and the response to antidepressants.
Chang HS; Won E; Lee HY; Ham BJ; Lee MS
Behav Brain Res; 2015 Oct; 292():116-24. PubMed ID: 26055202
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptides and the hypothalamic-pituitary-adrenocortical (HPA) system: review of recent research strategies in depression.
Hatzinger M
World J Biol Psychiatry; 2000 Apr; 1(2):105-11. PubMed ID: 12607206
[TBL] [Abstract][Full Text] [Related]
17. Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects.
Künzel HE; Zobel AW; Nickel T; Ackl N; Uhr M; Sonntag A; Ising M; Holsboer F
J Psychiatr Res; 2003; 37(6):525-33. PubMed ID: 14563384
[TBL] [Abstract][Full Text] [Related]
18. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
Friess E; Schmid D; Modell S; Brunner H; Lauer CJ; Holsboer F; Ising M
J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
[TBL] [Abstract][Full Text] [Related]
19. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
Sher L; Oquendo MA; Burke AK; Cooper TB; Mann JJ
J Affect Disord; 2013 Dec; 151(3):1108-12. PubMed ID: 23866302
[TBL] [Abstract][Full Text] [Related]
20. The parvocellular vasopressinergic system and responsiveness of the hypothalamic pituitary adrenal axis during chronic stress.
Aguilera G; Subburaju S; Young S; Chen J
Prog Brain Res; 2008; 170():29-39. PubMed ID: 18655869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
